MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 93 filers reported holding MYOVANT SCIENCES LTD in Q2 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $567,885 | -63.0% | 21,064 | -75.3% | 0.00% | -66.7% |
| Q3 2022 | $1,533,000 | +203.6% | 85,345 | +110.0% | 0.01% | +200.0% |
| Q2 2022 | $505,000 | +8.4% | 40,636 | +16.2% | 0.00% | -25.0% |
| Q1 2022 | $466,000 | +41.6% | 34,960 | +65.5% | 0.00% | +33.3% |
| Q4 2021 | $329,000 | -67.8% | 21,125 | -53.6% | 0.00% | -76.9% |
| Q3 2021 | $1,022,000 | +263.7% | 45,553 | +268.9% | 0.01% | +333.3% |
| Q2 2021 | $281,000 | +0.4% | 12,349 | -9.4% | 0.00% | -25.0% |
| Q1 2021 | $280,000 | -69.8% | 13,624 | -59.4% | 0.00% | -69.2% |
| Q4 2020 | $926,000 | +482.4% | 33,521 | +195.7% | 0.01% | +550.0% |
| Q3 2020 | $159,000 | -62.7% | 11,336 | -45.1% | 0.00% | -71.4% |
| Q2 2020 | $426,000 | -4.1% | 20,657 | -64.8% | 0.01% | -41.7% |
| Q1 2020 | $444,000 | -41.4% | 58,763 | +20.3% | 0.01% | -14.3% |
| Q4 2019 | $758,000 | +262.7% | 48,840 | +21.7% | 0.01% | +250.0% |
| Q3 2019 | $209,000 | -36.7% | 40,146 | +10.1% | 0.00% | -33.3% |
| Q2 2019 | $330,000 | +10900.0% | 36,479 | +19833.9% | 0.01% | – |
| Q3 2017 | $3,000 | -92.1% | 183 | -94.1% | 0.00% | -100.0% |
| Q4 2016 | $38,000 | – | 3,081 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| VitalStone Financial, LLC | 15 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $27 | 0.00% |